Compare Stocks → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSE:DNPNASDAQ:IBBNYSE:NUV Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDNPDNP Select Income Fund$8.84$8.91$8.09▼$11.18$3.14B0.47625,993 shs396,538 shsIBBiShares Biotechnology ETF$126.49+0.7%$134.45$111.83▼$141.16$7.03B0.731.80 million shs833,034 shsNUVNuveen Municipal Value Fund$8.45$8.63$7.86▼$8.93$1.75B0.33417,896 shs254,350 shsThe Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDNPDNP Select Income Fund+0.11%+0.74%-2.64%-0.11%-15.81%IBBiShares Biotechnology ETF-1.64%+0.83%-7.51%-7.15%-2.38%NUVNuveen Municipal Value Fund-0.59%-0.41%-2.14%-1.91%-3.59%These AI trades triggered this morning (545% return) (Ad)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free CopyMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDNPDNP Select Income FundN/AN/AN/AN/AN/AN/AN/AN/AIBBiShares Biotechnology ETFN/AN/AN/AN/AN/AN/AN/AN/ANUVNuveen Municipal Value FundN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDNPDNP Select Income FundN/AN/AN/AN/AIBBiShares Biotechnology ETF0.00N/A$155.7323.11% UpsideNUVNuveen Municipal Value FundN/AN/AN/AN/ACurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDNPDNP Select Income FundN/AN/AN/AN/AN/AN/AIBBiShares Biotechnology ETFN/AN/AN/AN/AN/AN/ANUVNuveen Municipal Value FundN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDNPDNP Select Income FundN/AN/A0.00∞N/AN/AN/AN/A6/28/2024 (Estimated)IBBiShares Biotechnology ETFN/AN/A0.00∞N/AN/AN/AN/AN/ANUVNuveen Municipal Value FundN/AN/A0.00∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDNPDNP Select Income Fund$0.788.82%N/AN/AN/AIBBiShares Biotechnology ETF$0.410.32%N/AN/AN/ANUVNuveen Municipal Value Fund$0.344.02%N/AN/AN/ALatest IBB, DNP, and NUV DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/20/2024DNPDNP Select Income Fund--$0.06508.6%6/28/20246/28/20247/10/20243/19/2024DNPDNP Select Income Fund--$0.06508.6%5/31/20245/31/20246/10/20243/15/2024DNPDNP Select Income FundMonthly$0.06508.6%4/29/20244/30/20245/10/20244/1/2024NUVNuveen Municipal Value FundMonthly$0.02904.03%4/12/20244/15/20245/1/20243/1/2024NUVNuveen Municipal Value FundMonthly$0.02904.01%3/14/20243/15/20244/1/20243/20/2024IBBiShares Biotechnology ETFQuarterly$0.12603/21/20243/22/20243/27/20242/1/2024NUVNuveen Municipal Value FundMonthly$0.02903.93%2/14/20242/15/20243/1/20241/30/2024DNPDNP Select Income Fund$0.06508.62%1/30/20241/31/20242/12/2024(Data available from 1/1/2013 forward)OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDNPDNP Select Income Fund8.51%IBBiShares Biotechnology ETF62.45%NUVNuveen Municipal Value Fund22.50%Insider OwnershipCompanyInsider OwnershipDNPDNP Select Income Fund0.06%IBBiShares Biotechnology ETFN/ANUVNuveen Municipal Value Fund1.00%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableDNPDNP Select Income FundN/A354.86 million354.64 millionNot OptionableIBBiShares Biotechnology ETFN/A55.55 millionN/AOptionableNUVNuveen Municipal Value Fund640207.54 million205.47 millionNot OptionableIBB, DNP, and NUV HeadlinesSourceHeadlineInternational Assets Investment Management LLC Acquires 110,555 Shares of Nuveen Municipal Value Fund, Inc. (NYSE:NUV)marketbeat.com - April 23 at 4:16 AMTo Make Greener Buildings, Try Innovating around the Edgesinsights.som.yale.edu - April 18 at 10:20 PMNuveen Municipal Value Fund, Inc. (NYSE:NUV) Short Interest Updatemarketbeat.com - April 12 at 12:35 AMInflation report sparks large UST selloff, munis outperform for nowbondbuyer.com - April 11 at 9:38 AMRaymond James Financial Services Advisors Inc. Buys 191,461 Shares of Nuveen Municipal Value Fund, Inc. (NYSE:NUV)marketbeat.com - April 5 at 4:17 AMNuveen Municipal Value Fund, Inc. Announces Monthly Dividend of $0.03 (NYSE:NUV)marketbeat.com - April 3 at 9:16 AMRaymond James & Associates Sells 868,726 Shares of Nuveen Municipal Value Fund, Inc. (NYSE:NUV)marketbeat.com - April 3 at 4:27 AMNuveen Municipal Value Fund, Inc. (NYSE:NUV) Sees Significant Drop in Short Interestmarketbeat.com - March 30 at 8:39 AMLarge primary slate, weaker secondary tone forces higher yieldsbondbuyer.com - March 28 at 3:16 PMPettinga Financial Advisors LLC Takes Position in Nuveen Municipal Value Fund, Inc. (NYSE:NUV)marketbeat.com - March 27 at 6:33 PMLook For Munis To Behave Like Bonds Again In 2024fa-mag.com - March 13 at 2:12 PMIn 2024, Look For Munis To Behave Like Bonds Againfa-mag.com - March 12 at 7:37 PMNuveen Municipal Value Fund, Inc. (NUV)uk.finance.yahoo.com - February 24 at 10:43 AMNuveen North Carolina Municipal Bond Fund;Iwsj.com - January 23 at 6:30 PMNuveen AMT-Free Municipal Income Fund's Dividend Analysisfinance.yahoo.com - January 10 at 2:30 PMNuveen Municipal Value Fund declares $0.029 dividendmsn.com - January 4 at 10:11 AMNuveen Pennsylvania Municipal Bond Fund;Awsj.com - December 16 at 2:27 PMNuveen Minnesota Municipal Bond Fund;Awsj.com - December 16 at 12:04 AMNuveen AMT-Free Municipal Value Fund goes ex dividend todaymsn.com - December 14 at 9:27 AMNuveen Municipal Value Fund goes ex dividend todaymsn.com - December 14 at 9:27 AMNUV: Investment-Grade Municipal Exposure With Little Leverageseekingalpha.com - November 17 at 6:53 AMSaba Capital Management, L.P. Bolsters Position in Nuveen Pennsylvania Quality Municipal Income Fundfinance.yahoo.com - November 14 at 4:28 PMSaba Capital Management, L.P. Bolsters Position in Nuveen New Jersey Quality Municipal Income Fundfinance.yahoo.com - November 13 at 7:45 PMNuveen California Municipal Value Fund goes ex-dividend tomorrowmsn.com - November 13 at 2:45 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines3 Value Stocks Too Small For Buffett’s PortfolioMarch 28, 2024 12:16 PMView 3 Value Stocks Too Small For Buffett’s Portfolio3 Stocks Leading the U.S. Agriculture ComebackApril 26, 2024 10:10 AMView 3 Stocks Leading the U.S. Agriculture ComebackStock market today: Alphabet and Microsoft help Wall Street clinch its best week in nearly 6 monthsApril 26, 2024 3:21 AMView Stock market today: Alphabet and Microsoft help Wall Street clinch its best week in nearly 6 monthsBiotech Sector Nears Breakout: Will it Outperform in Q2?April 3, 2024 6:10 AMView Biotech Sector Nears Breakout: Will it Outperform in Q2?Is Norwegian Cruise Lines Ready to Catch Up to Royal Caribbean?April 16, 2024 6:15 AMView Is Norwegian Cruise Lines Ready to Catch Up to Royal Caribbean?All Headlines Company DescriptionsDNP Select Income FundNYSE:DNPDNP Select Income Fund Inc. is a closed ended balanced mutual fund launched by Virtus Investment Partners, Inc. The fund is managed by Duff & Phelps Investment Management Co. It invests in the public equity and fixed income markets of the United States. For the fixed income portion, the fund invests in bonds. It seeks to invest in stocks of companies operating in the Utility sector. The fund invests in stocks of companies across all market capitalizations. It benchmarks the performance of its portfolio against the S&P 500 Utilities Index and Barclays Capital U.S. Utility Bond Index. DNP Select Income Fund Inc. was formed on November 26, 1986 and is domiciled in the United States.iShares Biotechnology ETFNASDAQ:IBBiShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.Nuveen Municipal Value FundNYSE:NUVNuveen Municipal Value Fund, Inc. is a closed-ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the fixed income markets of the United States. The fund also invests some portion of its portfolio in derivative instruments. It invests in undervalued municipal securities and other related investments the income, exempt from regular federal income taxes that are rated Baa or BBB or better. It employs fundamental analysis with bottom-up stock picking approach to create its portfolio. The fund benchmarks the performance of its portfolio against the Standard & Poor's (S&P) National Municipal Bond Index. Nuveen Municipal Value Fund, Inc. was formed on April 8, 1987 and is domiciled in the United States. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.